Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis.
about
Effect of hepatic function on the EC50 of midazolam and the BIS50 at the time of loss of consciousness.Review article: prescribing medications in patients with cirrhosis - a practical guide.The pharmacokinetics of midazolam following orthotopic liver transplantationReduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosis.Update of endoscopy in liver disease: more than just treating varices.Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteersIntestinal first pass metabolism of midazolam in liver cirrhosis --effect of grapefruit juiceComparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach.CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores.Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.Sedation for fibreoptic bronchoscopy.Pharmacokinetics cannot explain the increased effective dose requirement for morphine and midazolam in rats during their extended administration alone or in combination.Propofol sedation for upper gastrointestinal endoscopy in patients with liver cirrhosis as an alternative to midazolam to avoid acute deterioration of minimal encephalopathy: a randomized, controlled study.Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations.Safety and effectiveness of low-dose propofol sedation during and after esophagogastroduodenoscopy in child A and B cirrhotic patients.Irreversible CYP3A inhibition accompanied by plasma protein-binding displacement: a comparative analysis in subjects with normal and impaired liver function.Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience.Randomized controlled trial for endoscopy with propofol versus midazolam on psychometric tests and critical flicker frequency in people with cirrhosis.Plasma concentrations of midazolam during continuous subcutaneous administration in palliative care.
P2860
Q34029472-EA78F672-9FDC-4F71-80DA-E4895C5DB81FQ34342554-7185CB3B-C020-40D1-8219-54B697734443Q34397693-42F5D34F-3AD5-4762-9E64-F489CE31106FQ34659732-7CB4876A-7BDE-45BF-8248-E79C5AB635A4Q35738416-DE018DC9-019A-4166-93AB-4FFE696EA644Q35803666-A9D25281-1A4E-4E35-A2FE-818BD73CBCD3Q35803984-F404FAAA-42C0-413C-98AB-E33DC159446DQ35825944-4A064333-90E8-46F5-B5B4-DE65CC48A659Q37317619-EB0730A1-1816-477C-81E5-FD8865CFD483Q37492051-262F5717-7EB8-4420-A512-A9D7400EF239Q38152329-2D9C16F8-0302-4A6A-B279-022CB52842CFQ38735582-3024C556-61BC-48EC-A067-D3038BE7064EQ39149746-994C0064-5508-44C7-8941-5C353E967B03Q43265561-37C60F60-1D0B-471E-9893-8A2A49EC3EC0Q44053384-71BD28BF-07B7-4F5E-BBA9-E5762CC15516Q46047248-9058794D-F412-4688-99D0-A97776D17135Q46237124-0FC711C1-BC6D-4304-BA5B-10AB6790DB45Q46937926-0FA93F09-32E8-4C91-810B-8FAE73526DE0Q48141443-D104694A-D1BE-43FF-95DD-FDD72AE367B6Q51646210-ECAD52E8-9A73-4683-9B71-E896193AEBE5
P2860
Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Pharmacokinetics and pharmacod ...... th severe alcoholic cirrhosis.
@en
type
label
Pharmacokinetics and pharmacod ...... th severe alcoholic cirrhosis.
@en
prefLabel
Pharmacokinetics and pharmacod ...... th severe alcoholic cirrhosis.
@en
P2093
P2860
P356
P1433
P1476
Pharmacokinetics and pharmacod ...... th severe alcoholic cirrhosis.
@en
P2093
MacGilchrist AJ
Watkinson G
P2860
P304
P356
10.1136/GUT.27.2.190
P407
P577
1986-02-01T00:00:00Z